Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines

  title={Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines},
  author={Jamaica Roanne Briones and Pattarawalai Talungchit and Montarat Thavorncharoensap and Usa Chaikledkaew},
  journal={BMC Health Services Research},
Background The World Health Organization (WHO) recommends oxytocin as the drug of choice for postpartum hemorrhage (PPH) prevention. However, the WHO has also recently considered carbetocin for PPH prevention, but only if carbetocin were a cost-effective choice in the country. Consequently, we determined the cost-effectiveness and budgetary impact of carbetocin against oxytocin in the Philippines. Methods A cost-utility analysis using a decision tree was done to compare the costs and outcomes… Expand

Figures and Tables from this paper

Heat stable carbetocin vs. oxytocin for the prevention of post-partum hemorrhage in emergency caesarean delivery: a randomized controlled trial
Heat stable carbetocin is effective in reducing additional uterotonics use compared to oxytocin without clinically significant change in blood pressure or pulse rate, therefore, can be a potential alternative in Iraq. Expand
The effect of trehalose, antioxidants, and acetate buffer concentration on oxytocin stability
Despite trehalose's reputation as a great stabilizer for biomolecules, it also had small to negligible effect on oxytocin stability at concentrations up to 1 M in acetate buffer, which was surprising given the present literature ontrehalose as a stabilizing agent for various biomolecule, including proteins and lipids. Expand


Analysis of the cost-effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador.
Carbetocin is as efficacious and safe as oxytocin for primary prevention of hemorrhage in cesarean delivery in Ecuador and is highly cost effective for reducing the need for additional uterotonic drugs in both emergency and elective cesAREan delivery. Expand
Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia.
In case of elective cesarean delivery, carbetocin is a dominant alternative in the prevention of PPH compared with oxytocin; however, it presents higher costs than Oxytocin, with similar effectiveness, in cases of vaginal delivery. Expand
Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima, Peru.
Carbetocin is more cost-effective than oxytocin for prevention of uterine hemorrhage after cesarean delivery and requires fewer additional uterotonic agents, had fewer hemorrhages and received fewer blood transfusions. Expand
A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections
This study demonstrates that carbetocin also reduces post-partum haemorrhage, use of blood and blood products and midwifery recovery time in the setting of caesarean section and delivers an overall substantial cost benefit. Expand
A Systematic Review of the Cost-effectiveness of Uterotonic Agents for the Prevention of Postpartum Hemorrhage
There is a lack of evidence on the cost-effectiveness of uterotonic agents and a need for more rigorous economic evaluations, but oxytocin was found to be the least costly uterusotonic agent for preventing PPH during vaginal birth when adverse events were considered. Expand
Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials
  • B. Jin, Yongming Du, Fubin Zhang, Kemei Zhang, Lu-lu Wang, L. Cui
  • Medicine
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2016
Carbetocin has been associated with a similar low incidence of adverse effects to oxytocin and at least as effective as syntometrine and may become an alternative uterotonic agent for the prevention of postpartum hemorrhage. Expand
Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis.
At list price, the introduction of carbetocin appears to provide improved clinical outcomes along with cost savings, though this is subject to uncertainty regarding the underlying data in efficacy, resource use, and cost. Expand
Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin?
A clinical and financial evaluation undertaken at a United Kingdom District General Hospital surrounding the introduction of carbetocin for prophylaxis against postpartum haemorrhage at caesarean deliveries found no clinically significant benefit, however associated costs increased by £18.52/patient. Expand
Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
The three most effective drugs for prevention of Postpartum haemorrhage were ergometrine plus oxytocin combination, carbetocin, and misoprostol plus oxyocin combination - the drug currently recommended by the WHO. Expand
Heat‐Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth
Heat‐stable carbetocin was noninferior to oxytocin for the prevention of blood loss of at least 500 ml or the use of additional uterotonic agents in a large trial of postpartum hemorrhage prevention. Expand